Innovations in High Blood Pressure Intervention Benefit Patients with Resistant Hypertension
PALO ALTO, Calif., FRANKFURT, Germany, May 17, 2025 /PRNewswire/ -- May 17, 2025, is World Hypertension Day, a day dedicated to raising awareness about high blood pressure, also known as the "silent killer" because many people do not know they have it and, over time, it can lead to serious health issues. The theme of World Hypertension Day, "Measure Your Blood Pressure Accurately, Control It, Live Longer!" highlights the importance of not only awareness but also accurate monitoring, diagnosis, and treatment of hypertension.
According to a report from the World Health Organization, the number of adults with hypertension doubled between 1990 and 2019 from 650 million to 1.3 billion. The report also states that only 54 percent of adults with hypertension are diagnosed and only 42 percent receive treatment. And recent studies1,2 have suggested that BP assessment in the clinical setting can often get a hypertension diagnosis wrong or miss it completely. Left undetected or uncontrolled, hypertension is a leading contributor to serious health risks, including heart attack, stroke and kidney disease, making accurate diagnosis, monitoring and treatment of the condition critical.
About one-third of the patients who are treated for hypertension remain uncontrolled despite making healthy lifestyle changes and taking more than three medications. For these patients, innovation and investment in new solutions are vital to achieve blood pressure control and realize a healthier future. From pharmaceutical treatments to technology, patients need new therapies that can provide life-changing results. This includes medical device-based therapies, like the Paradise™ Ultrasound Renal Denervation (uRDN) system, an additional treatment option for patients who remain uncontrolled and at elevated cardiovascular risk despite standard lifestyle changes and treatment with oral medications.
The Paradise uRDN system is a first-of-its-kind ultrasound-based RDN technology designed to lower blood pressure by denervating the sympathetic nerves surrounding the renal arteries, reducing the overactivity that can lead to hypertension. The Paradise uRDN system delivers two to three doses of 360-degree ultrasound energy — lasting seven seconds each — through the main renal arteries to the surrounding nerves.* The Paradise catheter features the exclusive HydroCooling™ system, which circulates sterile water through the balloon catheter during the procedure to help protect the renal artery wall. This minimally invasive procedure is supported by many medical societies including the American Heart Association, the American College of Cardiology, the European Society of Cardiology and others.
"Taking a risk-based approach to hypertension makes sense and this is why the medical societies are increasingly behind it," said Prof. Andrew Sharp, University College Dublin and The Mater Misericordiae Hospital, Dublin, Ireland. "Blood pressure reductions of just 5 to 10mmHg can have a significant impact on the risk of cardiovascular complications, such as stroke and heart attack, but gain is greatest in those who are most at risk, such as patients who also have other risk factors for cardiovascular health such as diabetes. Early blood pressure control may also limit the vascular aging process and yet over half of patients worldwide are not even at the basic standard of control of 140/90mmHg. With guidelines now suggesting lower BP targets of 130/80 for many, new treatments in this space are welcome. Renal denervation is a recently approved tool to safely aid in blood pressure lowering throughout the 24-hour cycle and is independent of patient adherence to medication. The procedure shows an excellent safety profile and typically takes under an hour to perform, with lasting BP reductions demonstrated."
Recor Medical – the manufacturer of the Paradise System - has been focused on developing and testing uRDN for the treatment of hypertension since 2009, and completed three independently powered, sham-controlled, randomized clinical trials, all which demonstrate the efficacy and safety of the Paradise System. Recor has also initiated the US Global Paradise System (GPS) Post-Approval Study to collect real-world clinical evidence with long-term follow-up in 1,000 patients with uncontrolled hypertension in the United States.
The Paradise uRDN system is indicated to reduce blood pressure as an adjunctive treatment in hypertension patients in whom lifestyle modifications and antihypertensive medications do not adequately control blood pressure. A physician will make a medical assessment to determine if a patient is a candidate for ultrasound renal denervation. The most common risks include pain, vascular access site complications and vasospasm. Full important risk information can be viewed here.
*Anatomies vary. See Paradise IFU for treatment strategies.
Liu H et al.: Arm Position and Blood Pressure Readings. The ARMS Crossover Randomized Clinical Trial. JAMA Intern Med. 2024;184(12):1436-1442. doi:10.1001/jamainternmed.2024.5213
https://newsroom.heart.org/news/high-blood-pressure-while-lying-down-linked-to-higher-risk-of-heart-health-complications
About Recor Medical, Inc.Recor Medical, headquartered in Palo Alto, Calif., a wholly owned subsidiary of Otsuka Medical Devices Co., Ltd., is a medical technology company focused on transforming the management of hypertension. Recor has pioneered the use of the Paradise Ultrasound Renal Denervation system for the treatment of hypertension. The Paradise uRDN system is an investigational device in Japan, is FDA approved in the United States, and bears the CE mark. Recor has reported positive outcomes in three independent, randomized, sham-controlled studies of the Paradise uRDN system in patients with mild-to-moderate and resistant hypertension. In addition, Recor is conducting the Global Paradise System ("GPS") Registry in the European Union and the UK, and has initiated the US GPS post-approval study in the United States.http://www.recormedical.com/
About Otsuka Medical Devices Co., Ltd.Otsuka Medical Devices Co., Ltd. engages in the global development and commercialization of medical devices that provide new therapeutic options in areas where patient needs cannot be met through pharmaceutical or other conventional treatment. Otsuka Medical Devices is a subsidiary of Otsuka Holdings Co., Ltd. (www.otsuka.com/en), a global healthcare company listed on the Tokyo Stock Exchange (JP 4578).
https://www.omd.otsuka.com/en/
Photo: https://mma.prnewswire.com/media/2689174/RecorMedical_BP_Measure.jpgLogo: https://mma.prnewswire.com/media/2689173/Recor_Medical_Logo.jpg
View original content to download multimedia:https://www.prnewswire.com/news-releases/innovations-in-high-blood-pressure-intervention-benefit-patients-with-resistant-hypertension-302457998.html
SOURCE Recor Medical Inc.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Bloomberg
19 minutes ago
- Bloomberg
Whoop Refuses to Remove Blood Pressure Tool Despite FDA Warning
Whoop Inc., the maker of screen-less fitness bands, said it will not disable its blood-pressure tracking tool despite a request from the US Food and Drug Administration. The FDA last month sent a warning letter to Whoop stating that the company's Blood Pressure Insights feature, which both measures blood pressure and provides related feedback, means that the Whoop is operating as a medical device.
UPI
an hour ago
- UPI
Travel-related chikungunya cases in England climb nearly three-fold
Aug. 14 (UPI) -- The number of travel-related cases of chikungunya, a mosquito-borne viral infection, has nearly tripled in England during the first six months of the year compared to the same period last year, British health officials said Thursday. According to the latest data from the UK Health Security Agency, there have been 73 cases of the virus reported in England between January and June. During the same period in 2024, there were only 27 cases. The health agency said the 73 cases is the highest number recorded in this period to date. The majority of the infected patients had reported traveling to Sri Lanka, India and Mauritius, where there were infections associated with outbreaks in Indian Ocean countries, it said. Chikungunya is transmitted to humans by infected mosquitoes. Severe symptoms and death associated with the virus are rare, but can occur in babies and the elderly, especially those with serious health problems, according to the World Health Organization. Despite its lack of fatality, the disease can still cause fever and joint pain, which the World Health Organization says can be debilitating and prolonged. Other symptoms include joint swelling, muscle pain, headache, nausea, fatigue and rash. Two vaccines have been approved for use in several countries, including Britain. "Chikungunya can be a nasty disease and we're seeing a worrying increase in cases among travelers returning to the UK," Dr. Philip Veal, consultant in Public Health at UKHSA, said in a statement. "While this mosquito-borne infection is rarely fatal, it can causes severe joint and muscle pain, headaches, sensitivity to light and skin rashes. Thankfully, symptoms usually improve within a few weeks, but joint pain may last for months or longer." According to the European Center for Disease Prevention and Control, as of July, there have been 240,000 cases of the virus so far this year and 90 deaths in 16 countries. France has tested positive for 30 cases and Italy for one. However, France's Reunion Island -- located in the Indian Ocean, to the east of Madagascar -- is battling an epidemic of the virus. The Pacific Community, the principal scientific and technical organization supporting development in the Pacific region, said in a statement that the small island has confirmed 54,410 cases of the virus, including 28 deaths, so far this year. "Health authorities are urging heightened vigilance for travelers to La Reunion," SPC said, "visitors are advised to take preventive measures against mosquito bites, including the use of insect repellent, wearing long-sleeved clothing and staying in accommodations with screened windows or air conditioning." Earlier this month, the U.S. Centers for Disease Control and Prevention issued a travel warning for Americans thinking of visiting southern China over an outbreak of chikungunya there. The CDC states there are outbreaks in Bolivia, China's Guangdong Province, Kenya, Madagascar, Mauritius, Mayotte, Somalia and Sri Lanka.
Time Magazine
11 hours ago
- Time Magazine
More and More Americans Are Forgoing Alcohol. Why?
The percentage of adults in the U.S. who report drinking alcohol is at a record low, according to a Gallup poll released on Wednesday. Only 54% of adults said they consume alcohol—the smallest share since Gallup started tracking Americans' drinking behavior in 1939. And a majority of Americans (about 53%) said they believe that even just 'one or two drinks a day' is bad for their health. That's a leap from the roughly 25% of Americans who held this view from 2001 through 2011. Even the Americans who said they do drink alcohol reported consuming less of it than those in past polls. Just 24% said they'd had a drink in the past 24 hours—another record low. And 40% said they hadn't had an alcoholic beverage in more than a week—the highest figure in more than two decades. The decline is a recent one: From 1997 to 2023, the percentage of Americans who said they drank alcohol was 60% or higher, according to Gallup. That number dropped from 62% in 2023 to 58% in 2024 before reaching the record-low seen this year. Why are Americans drinking less? Researchers said these results, which were part of Gallup's annual Consumption Habits survey conducted in July, coincide with a growing body of research in recent years that has indicated that any amount of alcohol consumption may have negative health ramifications. While some studies over the years have indicated drinking moderate amounts of alcohol could have possible benefits, many health experts now say that there is substantial evidence of the risks associated with alcohol. In 2023, the World Health Organization said, 'When it comes to alcohol consumption, there is no safe amount that does not affect health.' And at the start of this year, then-U.S. Surgeon General Vivek Murthy proposed putting a label on bottles of beer, wine, and liquor to warn Americans that alcohol is a leading cause of cancer. Lydia Saad, Gallup Director of U.S. Social Research, stresses that her analysis of the poll notes a correlation between declining alcohol use and a growing percentage of Americans who believe moderate drinking is unhealthy—rather than asserting that the concerns are causing the trend. Dr. Ellen Burnham, a professor of medicine at the University of Colorado School of Medicine who was not involved in the Gallup poll, says she was a little surprised by Gallup's findings because she has often treated patients with alcohol-related conditions or complications, particularly in the past few years. While the research on the risks of alcohol consumption could be part of the reason for declining alcohol use, she says that might not be the whole explanation and posits other theories as well, including that some people might not have the disposable income to buy alcohol or may have pre-existing health conditions that could make them less inclined to drink. According to Saad's analysis, it doesn't appear that the decline in alcohol use is being caused by people turning to other mood-altering substances, based on previous data. Although marijuana use, for instance, has increased in the past decade, that number has been relatively stable in recent years. Burnham says it's promising that the Gallup poll found that fewer people are drinking overall. But she points out that many Americans still drink and have alcohol-related health complications, and that alcohol consumption varies depending on geographic region. 'I think it remains to be seen' whether the decline in alcohol consumption will continue, Burnham says. 'It's encouraging to see that some of the educational messaging is hopefully reaching an audience, and hopefully it's the audience that's engaging in risky drinking and is really rethinking about their drinking habits and how to diminish them or decrease them.' Younger people lead the trend—but fewer older adults are drinking, too For years, younger adults have been less likely to say they drink alcohol compared to middle-aged and older adults, according to Saad's analysis. That trend has only continued: 59% of younger adults in 2023 said they drank alcohol, compared to 50% in 2025. Experts who previously spoke with TIME suggested that a decline in drinking among younger adults could be driven by a variety of factors, including changing views of alcohol and socialization patterns in the age group. But fewer middle-aged and older adults are reporting drinking now compared to a couple years ago as well. 'Older folks have lived through the period when the medical advice was 'drinking could be beneficial to you,' so hearing that it's now harmful to your health is a 180 for them and so they have to mentally move a bigger distance to say 'maybe I shouldn't be drinking,'' Saad says, explaining a possible explanation behind this trend. Younger adults, meanwhile, have likely heard about the risks associated with alcohol since they became old enough to drink, 'so it's not, I think, as much of a behavior change for them … as it would be for their parents and grandparents who have to do a real pivot in terms of how they look at the risks of drinking,' she continues. A partisan split emerges In previous years, researchers found little difference in the drinking behaviors of people with varying political leanings. But the percentage of Republicans who report drinking has fallen significantly over the past couple years, according to Gallup's findings, opening a notable partisan gap. In 2023, 65% of Republicans said they drink, but that number plummeted to 46% in 2025. Meanwhile, that figure for Democrats has remained relatively steady, dropping just 3 percentage points from 64% in 2023 to 61% in 2024, and holding at 61% in 2025. Saad says analysts found that the declining alcohol use was 'largely just across the board among Republicans.' More research would need to be conducted to determine the reason for the partisan split, she says: so far, there's no theory strong enough to explain it.
